Use code Welcome25 on your first order  |  FREE 10ml BAC WATER WITH ALL $100+ ORders

SHOP Peptides
BPC 157 10mg
BPC 157 10mg - Image 2

BPC 157 10mg

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from human gastric juice, marketed for accelerating tissue repair, reducing inflammation, and healing musculoskeletal injuries like tendonitis, ligament tears, and muscle strains. Although it shows promise in animal studies, it lacks FDA approval for human use, is banned by WADA, and is often used via injection or oral capsules.

$64.99

547 in stock (can be backordered)

SKU BPC-15710mg Categories , , , ,

4

5

6

Description

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from human gastric juice, marketed for accelerating tissue repair, reducing inflammation, and healing musculoskeletal injuries like tendonitis, ligament tears, and muscle strains. Although it shows promise in animal studies, it lacks FDA approval for human use, is banned by WADA, and is often used via injection or oral capsules.

Key Aspects of BPC-157:
Benefits & Therapeutic Uses: Primarily studied for its potent healing properties, BPC-157 may enhance angiogenesis (new blood vessel formation), accelerate tendon-to-bone healing, repair damaged tendons, ligaments, and muscles, and reduce gastrointestinal inflammation. It is also investigated for neuroprotective properties and repairing organ damage.
Mechanism of Action: It functions as a stable peptide that mimics gastric juices, influencing multiple growth factors (e.g., VEGFR2) to speed up collagen synthesis and cell regeneration.
How It Is Taken: The compound is available as oral capsules or subcutaneous/intramuscular injections.
Timeline to Work: Some users report initial improvements in soft tissue injuries within 2–6 weeks, though results vary based on the severity of the condition.
Side Effects & Safety: While preclinical studies show it is generally well-tolerated, potential side effects in humans may include redness, swelling, or pain at the injection site, and, rarely, headaches or dizziness.
Regulatory Status: In 2023, the US FDA classified BPC-157 as a prohibited ingredient in compounded medications due to insufficient human safety data. It is also banned by WADA.
Disclaimer: BPC-157 is an experimental compound. Its safety and efficacy have not been established in large-scale human clinical trials.

Please confirm

This website contains peptides and is only available for purchase by adults (21+) only. They are not for human consumption, veterinary use, or medical applications. Products sold are intended for laboratory and research purposes only.

Peptides FOR SALE
Contact info
Email

support@purechainaminos.com

Follow Us
Instagram